UNSPSC 51132221: Aspirin/caffeine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN103. This VA Drug Class (CN103) classifies this compound as belonging to the group NON-OPIOID ANALGESICS.

UNSPSC 51132221 Aspirin/caffeine is a Commodity code that reflects state and local procurement of over-the-counter and generic pharmaceuticals, though the recent opportunities tagged under it span a broader pharmaceutical portfolio including naloxone, direct-to-manufacturer prescription programs, and multi-source generic drugs. State and local issuing bodies acquiring under this code include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and cooperative purchasing alliances administering multi-state pharmaceutical procurement (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The work encompasses procurement of finished pharmaceutical products for community health initiatives, emergency response inventory (such as opioid antagonists), and supply agreements serving multiple government jurisdictions and employee health plans. Vendors must comply with FDA manufacturing standards, Drug Supply Chain Security Act (DSCSA) requirements, cGMP certification, and E-Verify employment eligibility verification, with contracts typically including a probationary or initial performance period and fixed-fee or negotiated-pricing structures.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2026. Texas HHS Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a direct-to-manufacturer prescription program bypassing traditional pharmacy benefit managers and wholesalers. MMCAP, administered by the Minnesota Department of Administration, issued RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and over-the-counter products distributed through three authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson) with a March 26, 2026, proposal deadline and July 1, 2026, contract effective date. MMCAP procurement uses a 75-percent weighting on price competitiveness and requires vendors to maintain contractual relationships with at least two authorized wholesalers and carry commercial general liability insurance of $5,000,000 per occurrence.